Personal tools

MCL coexpression mm9:1422

From FANTOM5_SSTAR

Revision as of 16:14, 10 October 2012 by Autoedit (talk | contribs) (Created page with "{{MCL_coexpression_mm9|gostat_on_MCL_coexpression=GO:0042685;cardioblast cell fate specification;0.00569769352983071;16412!GO:0042684;cardioblast cell fate commitment;0.005697...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Phase1 CAGE Peaks

 Short description
Mm9::chr1:135811366..135811375,-p@chr1:135811366..135811375
-
Mm9::chr1:135811991..135811998,-p@chr1:135811991..135811998
-
Mm9::chr1:135817923..135817934,-p3@Prelp
Mm9::chr1:135817938..135817969,-p1@Prelp
Mm9::chr1:135817970..135817986,-p2@Prelp
Mm9::chr8:131209294..131209358,+p5@Itgb1


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0042685cardioblast cell fate specification0.00569769352983071
GO:0042684cardioblast cell fate commitment0.00569769352983071
GO:0010002cardioblast differentiation0.0113947627233114
GO:0045214sarcomere organization0.0182211315066188
GO:0031594neuromuscular junction0.0182211315066188
GO:0030239myofibril assembly0.0182211315066188
GO:0055002striated muscle cell development0.0182211315066188
GO:0055001muscle cell development0.0182211315066188
GO:0035051cardiac cell differentiation0.0182211315066188
GO:0031032actomyosin structure organization and biogenesis0.0182211315066188
GO:0048628myoblast maturation0.0182211315066188
GO:0048627myoblast development0.0182211315066188
GO:0005178integrin binding0.0182211315066188
GO:0001708cell fate specification0.0182211315066188
GO:0000082G1/S transition of mitotic cell cycle0.0182211315066188
GO:0042383sarcolemma0.0194242790689466
GO:0051146striated muscle cell differentiation0.0194242790689466
GO:0008305integrin complex0.0215051615186753
GO:0045445myoblast differentiation0.0215705580130174
GO:0051325interphase0.0222237577923401
GO:0051329interphase of mitotic cell cycle0.0222237577923401
GO:0048513organ development0.0242452063641671
GO:0032403protein complex binding0.0242452063641671
GO:0019717synaptosome0.0246555107125972
GO:0005201extracellular matrix structural constituent0.0251050382667859
GO:0042692muscle cell differentiation0.0251050382667859
GO:0007160cell-matrix adhesion0.0251050382667859
GO:0048741skeletal muscle fiber development0.0251050382667859
GO:0048747muscle fiber development0.0251050382667859
GO:0031589cell-substrate adhesion0.0254036841775843
GO:0043235receptor complex0.0255021912101114
GO:0048731system development0.0255021912101114
GO:0048469cell maturation0.0255021912101114
GO:0045596negative regulation of cell differentiation0.0284229123324066
GO:0007229integrin-mediated signaling pathway0.0287339879187794
GO:0021700developmental maturation0.0287339879187794
GO:0007519skeletal muscle development0.0291396984880458
GO:0048856anatomical structure development0.0291396984880458
GO:0045165cell fate commitment0.0291396984880458
GO:0051093negative regulation of developmental process0.0295444077178587
GO:0001701in utero embryonic development0.0329521095651926
GO:0014706striated muscle development0.0329521095651926
GO:0007275multicellular organismal development0.0329521095651926
GO:0045595regulation of cell differentiation0.0388340955699746
GO:0030036actin cytoskeleton organization and biogenesis0.0388340955699746
GO:0030029actin filament-based process0.0400656162891692
GO:0007517muscle development0.0400656162891692
GO:0007507heart development0.0401718168432316
GO:0008284positive regulation of cell proliferation0.0407341498512422
GO:0001501skeletal development0.0408222322428206
GO:0032502developmental process0.0469809866053202
GO:0043009chordate embryonic development0.0469809866053202
GO:0009792embryonic development ending in birth or egg hatching0.0469809866053202
GO:0000278mitotic cell cycle0.0469809866053202



Relative expression of the co-expression cluster over median <br>Analyst:



"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}